دورية أكاديمية

Predictive biomarkers of response and survival following immunotherapy with a PD-L1 inhibitor benmelstobart (TQB2450) and antiangiogenic therapy with a VEGFR inhibitor anlotinib for pretreated advanced triple negative breast cancer

التفاصيل البيبلوغرافية
العنوان: Predictive biomarkers of response and survival following immunotherapy with a PD-L1 inhibitor benmelstobart (TQB2450) and antiangiogenic therapy with a VEGFR inhibitor anlotinib for pretreated advanced triple negative breast cancer
المؤلفون: Han, Yiqun, Wang, JiayuAff1, IDs41392023016725_cor2, Sun, Tao, Ouyang, Quchang, Li, Jianwen, Yuan, Jie, Xu, BingheAff1, IDs41392023016725_cor7
المصدر: Signal Transduction and Targeted Therapy. 8(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:20593635
DOI:10.1038/s41392-023-01672-5